The primary outcome of our meta-analysis of the efficiency of GLP-1 RAs in patients with T2DM and NAFLD, included IHA, SAT, VAT, and Fibrosis-4 (FIB-4) index and the NAFLD fibrosis score (NFS). Here, GLP1R is linked to metabolic dysfunction-associated steatotic liver disease.